TAS106 Enhances Radiation-Induced Cell Death in Tumors
Author Information
Author(s): H Yasui, A Ogura, T Asanuma, A Matsuda, I Kashiwakura, M Kuwabara, O Inanami
Primary Institution: Hokkaido University
Hypothesis
TAS106 radiosensitises tumour cells through HIF-1α inhibition.
Conclusion
TAS106 can enhance the effectiveness of radiation therapy by increasing apoptosis in both normoxic and hypoxic tumor cells.
Supporting Evidence
- TAS106 reduced HIF-1α expression in both normoxic and hypoxic conditions.
- TAS106 enhanced apoptosis in X-irradiated tumor cells.
- The combination of TAS106 and radiation significantly decreased the hypoxic area in tumors.
- TAS106 treatment led to increased activation of caspase-3, indicating enhanced apoptosis.
Takeaway
TAS106 is a drug that helps make cancer cells more sensitive to radiation, which can help kill them better, especially when they are in low-oxygen areas.
Methodology
The study involved in vitro and in vivo experiments using human gastric adenocarcinoma cell lines and SCID mice to assess the effects of TAS106 on apoptosis and HIF-1α expression.
Limitations
The study primarily focused on specific cancer cell lines and may not generalize to all tumor types.
Participant Demographics
The study used human gastric adenocarcinoma cell lines and SCID mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website